The analyst is extremely bullish on MicroStrategy's preferred stocks, highlighting one called "stretch" for its attractive and tax-advantaged 10.53% effective yield. DFDV, a proxy for Solana (SOL), is presented as a clear buying opportunity as it trades below its asset value of $14.60 and has an upcoming warrant dividend. A basket of hyper-growth stocks including CorMedix (CRMD), The Real Brokerage (REAX), and Hims & Hers (HIMS) are seen as irrationally sold-off, creating excellent entry points. Specifically, CorMedix (CRMD) is described as "dirt cheap" near $10 a share, with projected revenue growth of 180%. These opportunities exist because the market is in "extreme fear," which is viewed as an ideal time to invest for the long term.

Bitcoin (BTC)

• The host notes that Bitcoin is down 14% from its recent peak and is currently in a "valley of despair". The price was mentioned as being at $107k for most of the day.
• The recent drop is partially attributed to a major liquidation event on exchanges that "scared a lot of people" and may lead to lawsuits and investigations.
• Despite the price drop, the host highlights several bullish long-term factors:
  • Institutional Adoption: The US government recently did another seizure, adding more Bitcoin to its strategic reserve.
  • Merchant Adoption: Square announced it will accept Bitcoin payments with zero fees until 2027.
  • Macroeconomic Tailwinds: An expected rate cut on October 29 and the 10-year Treasury yield hitting an all-time low are seen as very positive for risk assets like Bitcoin.

Takeaways

• The host has a long-term bullish outlook on Bitcoin, viewing the current price weakness as a temporary phase driven by market fear rather than a change in fundamentals.
• The combination of growing adoption (Square, government reserves) and a favorable macroeconomic environment (lower interest rates) is seen as a strong foundation for future price appreciation.
• The host believes the current market is in "extreme fear", which historically presents a good buying opportunity for long-term investors.

MicroStrategy (MSTR) & Related Securities

• The host refers to the company as "Strategy", a well-known Bitcoin proxy led by Michael Saylor.
• The stock is experiencing a "slow bleed" alongside Bitcoin's price drop.
• Its performance is closely tied to Bitcoin. On the day of the recording, it fell 1.58x as much as Bitcoin, which is slightly worse than the company's target of a 1.5x multiplier.
• The host notes that MSTR has held up significantly better than other crypto treasury companies like Nakamoto, Strive, or Metaplanet, which have lost up to 95% of their value.
• The Market-to-Net-Asset-Value (MNAV) is at 1.39, indicating a slow compression.

MicroStrategy Preferreds ("strike" and "stretch")

• The host is extremely bullish on two of MicroStrategy's preferred stock offerings, which they call "strike" and "stretch".
• A major benefit is that the dividends are classified as a "return of capital", meaning they are effectively tax-free for 8-12 years, as they just reduce your cost basis.
• "strike" is described as "highly undervalued," trading near its lows and only 8% above its launch price, despite falling interest rates which should theoretically increase its value.
• "stretch" is highlighted for its low volatility (5%) and a high effective yield of 10.53%, which is presented as a very attractive alternative to the 10-year Treasury's yield of 3.97%.

Takeaways

• MSTR is viewed as a premier, more stable way to gain leveraged exposure to Bitcoin compared to smaller, more volatile crypto-related companies.
• The preferred stocks, "strike" and "stretch", are presented as a compelling, "highly undervalued" opportunity for investors who are bullish on Bitcoin and want to generate high, tax-advantaged yield. The host suggests these are a much better investment than government bonds for those who believe in the long-term debasement of fiat currency.

DFDV (Solana Proxy)

• DFDV is a company that holds Solana (SOL), acting as a stock market proxy for the cryptocurrency.
• The host's interest in the stock increased significantly after the company announced a warrant dividend: for every 10 shares owned, an investor will receive a warrant with a set exercise price in 2028. This is described as a "major dividend".
• The stock is currently trading at $13.79, which the host notes is below its Net Asset Value (NAV) of $14.60 per share.
• The company is actively accumulating more SOL, having recently purchased another 80,000 SOL.

Takeaways

• The host sees DFDV as a clear buying opportunity, calling the current environment a "deal-stober".
• The stock is considered undervalued because it's trading below the value of the Solana it holds on its balance sheet.
• The upcoming warrant issuance provides an additional, potentially valuable incentive for shareholders that the market seems to be ignoring.

Solana (SOL)

• The host is more bullish on the investment thesis for Solana than for Ethereum (ETH).
• They believe Solana is positioned to be a leading blockchain for future internet infrastructure, including insurance, exchanges, and payment systems.
• While acknowledging it's less established than Bitcoin or Ethereum, it's seen as the likely #3 cryptocurrency with significant growth potential.

Takeaways

• For investors looking for exposure to alternative blockchains beyond Bitcoin, the host prefers Solana over Ethereum.
• Investing in a proxy like DFDV is presented as a way to gain exposure to Solana's potential upside through the traditional stock market.

Hyper-Growth Stocks

The host discusses a basket of small-cap, hyper-growth stocks that have sold off sharply despite strong fundamentals. The overall sentiment is that the market is irrationally punishing these names, creating significant buying opportunities.

CorMedix (CRMD)

• The stock dropped 5%, briefly trading under $10.
• It's described as a leader in anti-infection medication with a projected revenue growth of 180% over the next 12 months and a 96% gross margin.
• The host calls the stock "dirt cheap" based on its valuation (EV / GP / RG of 0.03), noting it's cheaper than other popular growth stocks like Oscar (OSCR) and LifeMD (LFMD).

The Real Brokerage Inc. (REAX)

• The stock is down almost 6% to $3.69, its lowest point since the host began covering it.
• It's a real estate brokerage with projected sales growth of 50% over the next 12 months.
• The host is confused by the sell-off, arguing that falling interest rates (indicated by the low 10-year Treasury yield) should be a major tailwind for real estate companies like REAX.

Hims & Hers Health, Inc. (HIMS)

• The stock is down 7%, giving back recent gains.
• The host believes the market has already forgotten the major positive news about the company's expansion into the menopause treatment market.
• It's a "super hyper-growth stock" with projected sales growth of 47% over the next 12 months.

Takeaways

• The host believes the sell-off in high-quality, profitable, hyper-growth small-cap stocks like CRMD, REAX, and HIMS is disconnected from their strong business fundamentals.
• The current market environment, characterized by "extreme fear," is creating what the host sees as excellent entry points or "deals" in these names for investors with a long-term horizon.
• Specific catalysts, like falling interest rates for REAX or new market expansion for HIMS, are being ignored, suggesting the stocks are currently mispriced.